BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31115051)

  • 21. Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.
    Wang L; Guo H; Yang L; Dong L; Lin C; Zhang J; Lin P; Wang X
    Mol Cell Biochem; 2013 Jul; 379(1-2):7-18. PubMed ID: 23543150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
    PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
    Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
    Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA ES1 controls the proliferation of breast cancer cells by regulating the Oct4/Sox2/miR-302 axis.
    Keshavarz M; Asadi MH
    FEBS J; 2019 Jul; 286(13):2611-2623. PubMed ID: 30927330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells.
    Johari B; Ebrahimi-Rad M; Maghsood F; Lotfinia M; Saltanatpouri Z; Teimoori-Toolabi L; Sharifzadeh Z; Karimipoor M; Kadivar M
    Anticancer Agents Med Chem; 2017; 17(13):1786-1795. PubMed ID: 28403778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4.
    Long W; Zhao W; Ning B; Huang J; Chu J; Li L; Ma Q; Xing C; Wang HY; Liu Q; Wang RF
    J Mol Cell Biol; 2018 Apr; 10(2):147-160. PubMed ID: 29452418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter.
    Li J; Haque M; Shang C; Hassan B; Liu D; Chen W; Lai R
    Curr Issues Mol Biol; 2021 Jul; 43(2):543-557. PubMed ID: 34287231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
    Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
    J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression.
    Park GB; Kim D
    Oncol Rep; 2017 Nov; 38(5):3167-3176. PubMed ID: 28901470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
    Iida H; Suzuki M; Goitsuka R; Ueno H
    Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
    Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
    Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
    Chang CC; Hsu WH; Wang CC; Chou CH; Kuo MY; Lin BR; Chen ST; Tai SK; Kuo ML; Yang MH
    Cancer Res; 2013 Jul; 73(13):4147-57. PubMed ID: 23687336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.
    Lirdprapamongkol K; Chiablaem K; Sila-Asna M; Surarit R; Bunyaratvej A; Svasti J
    Biochem Biophys Res Commun; 2012 Jun; 422(3):429-35. PubMed ID: 22580004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and Characterization of Human Colon Adenocarcinoma Stem-Like Cells Based on the Endogenous Expression of the Stem Markers.
    Koshkin SA; Anatskaya OV; Vinogradov AE; Uversky VN; Dayhoff GW; Bystriakova MA; Pospelov VA; Tolkunova EN
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of transcriptional regulation of Oct4 (POU5F1) gene with distal enhancer].
    Nazarov IB; Krasnoborova VA; Mittenberg AG; Chikhirzhina EV; Davydov-Sinitsyn AP; Liskovykh MA; Tomilin AN
    Tsitologiia; 2013; 55(10):697-702. PubMed ID: 25509123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.